{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:17:59Z","timestamp":1778689079068,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20mk0101128"],"award-info":[{"award-number":["JP20mk0101128"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JP21am0101084"],"award-info":[{"award-number":["JP21am0101084"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.xphs.2022.01.023","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T08:21:59Z","timestamp":1643617319000},"page":"1363-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in Mice"],"prefix":"10.1016","volume":"111","author":[{"given":"Takaki","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-3722","authenticated-orcid":false,"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-2256","authenticated-orcid":false,"given":"Yuya","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Higashisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-6465","authenticated-orcid":false,"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ishii-Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.01.023_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bmb\/lds032","article-title":"Therapeutic application of monoclonal antibodies in cancer: advances and challenges","volume":"104","author":"Modjtahedi","year":"2012","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0022-2015","article-title":"Anti-TNF therapy","volume":"4","author":"Udalova","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.xphs.2022.01.023_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.06.001","article-title":"Antibody therapeutics and immunoregulation in cancer and autoimmune disease","volume":"64","author":"Yasunaga","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14712598.2011.552906","article-title":"Interferon in the treatment of chronic hepatitis C: a drug caught between past and future","volume":"11","author":"Vezali","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.023_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"Pegylation of therapeutic proteins","volume":"5","author":"Jevsevar","year":"2010","journal-title":"Biotechnol J"},{"issue":"10","key":"10.1016\/j.xphs.2022.01.023_bib0006","doi-asserted-by":"crossref","first-page":"25831","DOI":"10.3390\/ijms161025831","article-title":"Site-specific pegylation of therapeutic proteins","volume":"16","author":"Dozier","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.023_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.xphs.2019.08.009","article-title":"Physicochemical stability of monoclonal antibodies: a review","volume":"109","author":"Le Basle","year":"2020","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.xphs.2016.10.015","article-title":"Synergistic effect of cavitation and agitation on protein aggregation","volume":"106","author":"Torisu","year":"2017","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2022.01.023_bib0009","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.xphs.2017.05.035","article-title":"Friability testing as a new stress-stability assay for biopharmaceuticals","volume":"106","author":"Torisu","year":"2017","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2022.01.023_bib0010","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.xphs.2019.02.002","article-title":"An assessment of the ability of submicron- and micron-size silicone oil droplets in dropped Prefillable syringes to invoke early- and late-stage immune responses","volume":"108","author":"Krayukhina","year":"2019","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0011","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.xphs.2020.10.022","article-title":"Characterization of aggregated antibody-silicone oil complexes: from perspectives of morphology, 3D image, and Fc\u03b3 receptor activation","volume":"110","author":"Kiyoshi","year":"2021","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0012","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3549(15)00180-X","article-title":"Subvisible particle content, formulation, and dose of an erythropoietin peptide mimetic product are associated with severe adverse postmarketing events","volume":"105","author":"Kotarek","year":"2016","journal-title":"J Pharm Sci"},{"issue":"3-4","key":"10.1016\/j.xphs.2022.01.023_bib0013","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jbiotec.2009.05.012","article-title":"Enhanced circulation half-life of site-specific pegylated rhG-CSF: optimization of PEG molecular weight","volume":"142","author":"Zhai","year":"2009","journal-title":"J Biotechnol"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/bc500523t","article-title":"Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate","volume":"26","author":"Podobnik","year":"2015","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"Pegylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of pegylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.xphs.2022.01.023_bib0017","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/jps.24094","article-title":"The effect of protein PEGylation on physical stability in liquid formulation","volume":"103","author":"Holm","year":"2014","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.023_bib0018","doi-asserted-by":"crossref","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.023_bib0019","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2007.11.009","article-title":"The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of pegylated liposomes in rats","volume":"126","author":"Ishida","year":"2008","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/bc7004472","article-title":"Fully acid-degradable biocompatible polyacetal microparticles for drug delivery","volume":"19","author":"Paramonov","year":"2008","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0022","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejpb.2011.05.003","article-title":"Effects of PEG size on structure, function and stability of pegylated BSA","volume":"79","author":"Plesner","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1016\/j.xphs.2022.01.023_bib0023","doi-asserted-by":"crossref","first-page":"e42511","DOI":"10.1371\/journal.pone.0042511","article-title":"Biophysical characterization of Met-G-CSF: effects of different site-specific mono-pegylations on protein stability and aggregation","volume":"7","author":"Natalello","year":"2012","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0024","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.xphs.2022.01.023_bib0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1208\/s12249-020-01838-2","article-title":"The contribution of PEG molecular weights in pegylated emulsions to the various phases in the accelerated blood clearance (ABC) phenomenon in rats","volume":"21","author":"Jiao","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.xphs.2022.01.023_bib0026","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1002\/jps.23254","article-title":"Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species","volume":"101","author":"Li","year":"2012","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0027","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2009.0797","article-title":"Update on macrophage clearance of inhaled micro- and nanoparticles","volume":"23","author":"Geiser","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.chembiol.2015.04.006","article-title":"Macrophage activation: on par with LPS","volume":"22","author":"Bock","year":"2015","journal-title":"Chem Biol"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nri1334","article-title":"T-cell-B-cell cooperation","volume":"4","author":"Mitchison","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1440-1711.1999.00835.x","article-title":"The role of B7 costimulation in T-cell immunity","volume":"77","author":"Harris","year":"1999","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.023_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"issue":"35","key":"10.1016\/j.xphs.2022.01.023_bib0032","doi-asserted-by":"crossref","first-page":"29406","DOI":"10.1074\/jbc.M112.348946","article-title":"The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis","volume":"287","author":"Chan","year":"2012","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.023_bib0033","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-014-1541-x","article-title":"Small amounts of sub-visible aggregates enhance the immunogenic potential of Monoclonal Antibody Therapeutics","volume":"32","author":"Ahmadi","year":"2015","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:38:21Z","timestamp":1758361101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022354922000338"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in Mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}